Back to Search
Start Over
Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates.
- Source :
-
Dermatology & Therapy . Sep2024, Vol. 14 Issue 9, p2299-2330. 32p. - Publication Year :
- 2024
-
Abstract
- Atopic dermatitis often begins in infancy and follows a chronic course of exacerbations and remissions. The etiology is complex and involves numerous factors that contribute to skin barrier defect and inflammation. In the Middle East, the burden of atopic dermatitis is understudied. Epidemiological data specific to the Gulf region are scarce but reveal a prevalence of up to about 40% in the United Arab Emirates. Region-specific factors, such as the climate and the frequency of consanguineous marriages, may affect atopic dermatitis incidence, prevalence, and evolution over time. A panel of experts predominantly from the United Arab Emirates analyzed the evidence from published guidelines, and considered expert guidance and local treatment practices to develop clear recommendations for the management of atopic dermatitis in the United Arab Emirates. They encourage a systematic approach for the diagnosis and treatment, using disease severity scores and quality-of-life measurement tools. Treatment recommendations take into consideration both established therapies and the approved systemic biologics dupilumab and tralokinumab, and the Janus kinase inhibitors baricitinib, upadacitinib, and abrocitinib. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 21938210
- Volume :
- 14
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Dermatology & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 179604359
- Full Text :
- https://doi.org/10.1007/s13555-024-01247-4